THERAPEUTIC CLASS
The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model
Treatment of diabetes complications remains a substantial challenge. The aim of this study was to explore the
ability of the soy isoflavone genistein in attenuating the signs that follow diabetes onset: nociceptive
hypersensitivity, oxidative and inflammatory state,nerve growth factor(NGF)decrease and vascular dysfunctions.
Genistein (3 and 6 mg/kg) was administered to C57BL/6J streptozotocin diabetic mice from the 2nd till the 5th
week after disease induction. The hind paw withdrawal threshold to mechanical stimulation (tactile allodynia)
was evaluated by a von Frey filament.
No other version available